Dr. Barbara M. Wirostko, MD

Dr. Wirostko practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Wirostko's NPI, 1326045261, was assigned on July 7, 2005. Dr. Wirostko graduated from Columbia University College of Physicians and Surgeons in 1991. Dr. Wirostko holds Utah license 7496716-1205.

Dr. Wirostko's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Wirostko's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Wirostko is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Wirostko to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wirostko practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Wirostko's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Wirostko's licenses on file in 2 states: Utah and New York.

CMS data shows 474 Medicare services from Dr. Wirostko across 9 procedure codes in 2024, for 142 Medicare patients. Medicare paid $12,223 for them. Every service was in an office.

CMS counts 142 Medicare patients who saw Dr. Wirostko in 2024. The largest group is 65 to 74, with 68 patients. 68% of them have high cholesterol, and 59% have high blood pressure. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wirostko's median patient age at 76, with 53% women.

In 2024, Dr. Wirostko wrote 476 Medicare Part D claims for 86 patients. 69% of them were for generic drugs. CMS names the drug for 420 of them, across 9 drugs with 11 or more claims each, at $34,648 in total drug cost. In 2023, CMS named 408 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Wirostko for performance year 2024, reported as part of a group. Dr. Wirostko accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 73 papers to Dr. Wirostko, published from 2011 to 2024. 2022 was the busiest year, with 6. The most frequent topics are Intraocular Pressure, Glaucoma and Exfoliation Syndrome. Dr. Wirostko has published most often in J Glaucoma. Dr. Wirostko's most frequent co-authors are Robert Ritch, MD, Chase E. Paulson, MD and Louis Robert Pasquale, MD.

CMS Open Payments shows 34 general payments to Dr. Wirostko from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 97% of the total. Carl Zeiss Meditec, Inc. paid the most, $344,632.

Dr. Wirostko graduated from Columbia University College of Physicians and Surgeons in 1991.